WELL Health Technologies Corp.
WHTCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $920 | $776 | $569 | $302 |
| % Growth | 18.5% | 36.4% | 88.3% | – |
| Cost of Goods Sold | $557 | $404 | $266 | $149 |
| Gross Profit | $363 | $372 | $303 | $154 |
| % Margin | 39.5% | 48% | 53.3% | 50.8% |
| R&D Expenses | $0 | $3 | $3 | $0 |
| G&A Expenses | $237 | $213 | $176 | $108 |
| SG&A Expenses | $321 | $277 | $224 | $124 |
| Sales & Mktg Exp. | $85 | $64 | $48 | $16 |
| Other Operating Expenses | $72 | $63 | -$2 | $2 |
| Operating Expenses | $393 | $337 | $279 | $162 |
| Operating Income | -$30 | $35 | $23 | -$13 |
| % Margin | -3.3% | 4.5% | 4.1% | -4.2% |
| Other Income/Exp. Net | $39 | -$16 | -$6 | -$12 |
| Pre-Tax Income | $9 | $19 | $18 | -$25 |
| Tax Expense | -$20 | $3 | -$1 | $6 |
| Net Income | $33 | $0 | $1 | -$44 |
| % Margin | 3.5% | 0% | 0.2% | -14.5% |
| EPS | 0.13 | 0 | 0.006 | -0.23 |
| % Growth | 43,233.3% | -95.2% | 102.7% | – |
| EPS Diluted | 0.13 | 0 | 0.006 | -0.23 |
| Weighted Avg Shares Out | 247 | 237 | 221 | 191 |
| Weighted Avg Shares Out Dil | 255 | 237 | 221 | 191 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $36 | $33 | $22 | $8 |
| Depreciation & Amortization | $72 | $50 | $55 | $39 |
| EBITDA | $117 | $91 | $95 | $32 |
| % Margin | 12.7% | 11.8% | 16.7% | 10.6% |